ARK Genomic Revolution ETF (BATS:ARKG) Sets New 1-Year High – What’s Next?

Posted by Amy Steele on Sep 19th, 2026

Shares of ARK Genomic Revolution ETF (BATS:ARKG – Get Free Report) hit a new 52-week high on Thursday . The stock traded as high as $51.32 and last traded at $51.9010, with a volume of 2825670 shares traded. The stock had previously closed at $47.85.

ARK Genomic Revolution ETF Stock Performance

The business has a 50-day moving average price of $44.06 and a 200-day moving average price of $36.02.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. NewEdge Advisors LLC boosted its position in ARK Genomic Revolution ETF by 102.6% during the 1st quarter. NewEdge Advisors LLC now owns 24,092 shares of the company’s stock valued at $637,000 after acquiring an additional 12,202 shares in the last quarter. Group One Trading LLC raised its position in shares of ARK Genomic Revolution ETF by 168.3% in the 1st quarter. Group One Trading LLC now owns 45,861 shares of the company’s stock worth $1,212,000 after acquiring an additional 28,765 shares in the last quarter. Nwam LLC raised its position in shares of ARK Genomic Revolution ETF by 55.3% in the 2nd quarter. Nwam LLC now owns 31,704 shares of the company’s stock worth $1,333,000 after acquiring an additional 11,294 shares in the last quarter. Moran Wealth Management LLC raised its position in shares of ARK Genomic Revolution ETF by 79.6% in the 1st quarter. Moran Wealth Management LLC now owns 49,204 shares of the company’s stock worth $1,300,000 after acquiring an additional 21,811 shares in the last quarter. Finally, Gateway Wealth Partners LLC purchased a new stake in shares of ARK Genomic Revolution ETF during the 1st quarter worth $349,000.

ARK Genomic Revolution ETF Company Profile

(Get Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.